News
 

Patients who took amlodipine as part of an antihypertensive regimen experienced significantly fewer strokes over two decades, new long-term results from the ASCOT study show. This group showed an 18% decrease in stroke incidence compared with others taking an atenolol-based regimen.

Treatment with hookworm larvae was well tolerated in patients with multiple sclerosis (MS), and although the primary outcome was not met there was some evidence of a beneficial therapeutic effect in the first randomized clinical trial to evaluate such an approach.

Neurofilament light (NfL) and microRNAs (miRNAs) can help to predict the course that multiple sclerosis (MS) will take for individuals, according to two new studies published in Neurology and Acta Neurologica Scandinavica. The markers could help to identify progressive disease and facilitate treatment decisions.

A new analysis shows that rates of intracerebral hemorrhage (ICH) have not fallen during recent years, as has been seen with ischemic stroke, and rates appear to be increasing in the elderly.

A vegetarian diet rich in nuts, vegetables, and soy has been linked to a lower risk of both ischemic and hemorrhagic stroke, new research suggests.

Despite the ever-increasing acceptance of medical cannabis and its notably common use in patients with multiple sclerosis (MS), clinicians treating those patients still may be poorly informed about risks, benefits, regulations, and proper uses, experts say.